Search research articles
Contact Us
Filters
Showing results (111-120 of 186) with videos related to
Page
of 19
Sort By:
The Oncologist
|
November 25, 2016
Relationship Between Metformin Use and Recurrence and Survival in Patients With Resected Stage III Colon Cancer Receiving Adjuvant Chemotherapy: Results From North Central Cancer Treatment Group N0147 (Alliance)
Preet Paul Singh, Qian Shi, Nathan R Foster, et al.
Molecular Cancer Research : MCR
|
March 11, 2018
Landscape of Tumor Mutation Load, Mismatch Repair Deficiency, and PD-L1 Expression in a Large Patient Cohort of Gastrointestinal Cancers
Mohamed E Salem, Alberto Puccini, Axel Grothey, et al.
Journal for Immunotherapy of Cancer
|
March 22, 2024
Targeting refractory/recurrent neuroblastoma and osteosarcoma with anti-CD3×anti-GD2 bispecific antibody armed T cells
Maxim Yankelevich, Archana Thakur, Shakeel Modak, et al.
Molecular Therapy. Oncology
|
April 10, 2024
Differential landscape of immune evasion in oncogenic RAS-driven primary and metastatic colorectal cancers
Emil Lou, Joanne Xiu, Yasmine Baca, et al.
CA: a Cancer Journal for Clinicians
|
May 23, 2019
The current state of molecular testing in the treatment of patients with solid tumors, 2019
Wafik S El-Deiry, Richard M Goldberg, Heinz-Josef Lenz, et al.
International Journal of Cancer
|
May 26, 2020
Relationship between MLH1, PMS2, MSH2 and MSH6 gene-specific alterations and tumor mutational burden in 1057 microsatellite instability-high solid tumors
Mohamed E Salem, J Nicholas Bodor, Alberto Puccini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 17, 2025
Distinct Molecular and Clinical Features of Specific Variants of KRAS Codon 12 in Pancreatic Adenocarcinoma
Bach Ardalan, Aaron Ciner, Yasmine Baca, et al.
JNCI Cancer Spectrum
|
May 27, 2020
Contribution of Immunoscore and Molecular Features to Survival Prediction in Stage III Colon Cancer
Frank A Sinicrope, Qian Shi, Fabienne Hermitte, et al.
British Journal of Cancer
|
October 27, 2018
Safety and pharmacokinetics of MM-302, a HER2-targeted antibody-liposomal doxorubicin conjugate, in patients with advanced HER2-positive breast cancer: a phase 1 dose-escalation study
Pamela Munster, Ian E Krop, Patricia LoRusso, et al.
International Journal of Cancer
|
April 11, 2016
Alcohol consumption and colon cancer prognosis among participants in north central cancer treatment group phase III trial N0147
Amanda I Phipps, Qian Shi, Paul J Limburg, et al.
Page
of 19
Search research articles
Search
Showing results (111-120 of 186) with videos related to
Sort By:
Page
of 19
The Oncologist
|
November 25, 2016
Relationship Between Metformin Use and Recurrence and Survival in Patients With Resected Stage III Colon Cancer Receiving Adjuvant Chemotherapy: Results From North Central Cancer Treatment Group N0147 (Alliance)
Preet Paul Singh, Qian Shi, Nathan R Foster, et al.
Molecular Cancer Research : MCR
|
March 11, 2018
Landscape of Tumor Mutation Load, Mismatch Repair Deficiency, and PD-L1 Expression in a Large Patient Cohort of Gastrointestinal Cancers
Mohamed E Salem, Alberto Puccini, Axel Grothey, et al.
Journal for Immunotherapy of Cancer
|
March 22, 2024
Targeting refractory/recurrent neuroblastoma and osteosarcoma with anti-CD3×anti-GD2 bispecific antibody armed T cells
Maxim Yankelevich, Archana Thakur, Shakeel Modak, et al.
Molecular Therapy. Oncology
|
April 10, 2024
Differential landscape of immune evasion in oncogenic RAS-driven primary and metastatic colorectal cancers
Emil Lou, Joanne Xiu, Yasmine Baca, et al.
CA: a Cancer Journal for Clinicians
|
May 23, 2019
The current state of molecular testing in the treatment of patients with solid tumors, 2019
Wafik S El-Deiry, Richard M Goldberg, Heinz-Josef Lenz, et al.
International Journal of Cancer
|
May 26, 2020
Relationship between MLH1, PMS2, MSH2 and MSH6 gene-specific alterations and tumor mutational burden in 1057 microsatellite instability-high solid tumors
Mohamed E Salem, J Nicholas Bodor, Alberto Puccini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 17, 2025
Distinct Molecular and Clinical Features of Specific Variants of KRAS Codon 12 in Pancreatic Adenocarcinoma
Bach Ardalan, Aaron Ciner, Yasmine Baca, et al.
JNCI Cancer Spectrum
|
May 27, 2020
Contribution of Immunoscore and Molecular Features to Survival Prediction in Stage III Colon Cancer
Frank A Sinicrope, Qian Shi, Fabienne Hermitte, et al.
British Journal of Cancer
|
October 27, 2018
Safety and pharmacokinetics of MM-302, a HER2-targeted antibody-liposomal doxorubicin conjugate, in patients with advanced HER2-positive breast cancer: a phase 1 dose-escalation study
Pamela Munster, Ian E Krop, Patricia LoRusso, et al.
International Journal of Cancer
|
April 11, 2016
Alcohol consumption and colon cancer prognosis among participants in north central cancer treatment group phase III trial N0147
Amanda I Phipps, Qian Shi, Paul J Limburg, et al.
Page
of 19